ENTRY       D11146                      Drug
NAME        Tabelecleucel (USAN);
            Ebvallo (TN)
EFFICACY    Immunomodulator
  TYPE      Cellular therapy product, EBV-specific T-cell immunotherapy
COMMENT     Treatment of relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+PTLD)
BRITE       New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11146
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11146
DBLINKS     PubChem: 376219070
///
